DiagnoCure Licenses Colorectal Cancer ASRs From TDT

May 02, 2007

NEW YORK (GenomeWeb News) — DiagnoCure said yesterday that it plans to develop and sell two molecular diagnostic tests for cancer that it licensed from Targeted Diagnostics and Therapeutics.

DiagnoCure said the tests are designed to detect guanylyl cyclase C, or GCC. The company said the GCC gene appears normally in cells lining the intestines, but has only been found outside the intestine when colorectal cancer has metastasized.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Whirlwind Genetic Genealogy Year

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Getting Through the Backlog

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

Settlement After DNA Testing Questions

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

This Week in Nature

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.

Menu